Invesco’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-13,981
Closed -$392K 4233
2022
Q1
$392K Sell
13,981
-7,944
-36% -$218K ﹤0.01% 3515
2021
Q4
$598K Sell
21,925
-795
-3% -$21.5K ﹤0.01% 3314
2021
Q3
$618K Buy
22,720
+3,130
+16% +$77.4K ﹤0.01% 3332
2021
Q2
$334K Buy
19,590
+3,522
+22% +$65.9K ﹤0.01% 3586
2021
Q1
$336K Buy
16,068
+3,384
+27% +$78.1K ﹤0.01% 3509
2020
Q4
$291K Sell
12,684
-425,767
-97% -$8.11M ﹤0.01% 3433
2020
Q3
$7.15M Buy
438,451
+36,276
+9% +$657K ﹤0.01% 1827
2020
Q2
$5.45M Buy
402,175
+12,949
+3% +$151K ﹤0.01% 1946
2020
Q1
$4.61M Sell
389,226
-8,136
-2% -$180K ﹤0.01% 1937
2019
Q4
$9.89M Sell
397,362
-57,808
-13% -$1.17M ﹤0.01% 1768
2019
Q3
$7.74M Sell
455,170
-1,732,389
-79% -$31.5M ﹤0.01% 1866
2019
Q2
$49.8M Buy
2,187,559
+430,279
+24% +$11.6M 0.01% 1031
2019
Q1
$56.5M Buy
1,757,280
+3,434
+0.2% +$106K 0.02% 790
2018
Q4
$49.4M Sell
1,753,846
-17,560
-1% -$514K 0.02% 772
2018
Q3
$50.9M Buy
1,771,406
+117,879
+7% +$3.54M 0.02% 850
2018
Q2
$61.9M Buy
1,653,527
+201,823
+14% +$7.92M 0.02% 747
2018
Q1
$57.1M Buy
1,451,704
+1,274,042
+717% +$46.5M 0.02% 690
2017
Q4
$5.76M Buy
177,662
+43,708
+33% +$1.31M ﹤0.01% 1891
2017
Q3
$4.17M Buy
+133,954
New +$3.96M ﹤0.01% 2085
2016
Q1
Sell
-63,766
Closed -$1.44M 3789
2015
Q4
$1.44M Sell
63,766
-484
-0.8% -$9.57K ﹤0.01% 2742
2015
Q3
$1.5M Buy
64,250
+64,059
+33,539% +$1.77M ﹤0.01% 2683
2015
Q2
$5K Buy
+191
New +$5.01K ﹤0.01% 4240

Invesco's XENT Position: Q2 2022 in Review

Invesco sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 13,981 shares — an estimated $392K sold.

Invesco first reported a position in XENT in Q2 2015 and held it in 22 quarters. The position peaked at $61.9M in Q2 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Invesco reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 13,981 Intersect ENT, Inc shares in Q2 2022, an estimated $392K.
  • Invesco first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 22 quarters.
  • Invesco's Intersect ENT, Inc position peaked at $61.9M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.